1-7 of 7
David E. Neal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Engrailed-2 (EN2): A Tumor Specific Urinary Biomarker for the Early Diagnosis of Prostate Cancer

Free
Richard Morgan, Angela Boxall, Aagna Bhatt, Michael Bailey, Richard Hindley, Stephen Langley, Hayley C. Whitaker, David E. Neal, Mohammed Ismail, Hamish Whitaker, Nicola Annels, Agnieszka Michael, Hardev Pandha
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (5): 1090–1098.
https://doi.org/10.1158/1078-0432.CCR-10-2410
Published: 01 March 2011
View article titled, Engrailed-2 (EN2): A Tumor Specific Urinary Biomarker for the Early Diagnosis of Prostate Cancer
Open the PDF for Engrailed-2 (EN2): A Tumor Specific Urinary Biomarker for the Early Diagnosis of Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

LYRIC/AEG-1 Is Targeted to Different Subcellular Compartments by Ubiquitinylation and Intrinsic Nuclear Localization Signals

Free
Hayley J. Thirkettle, Joanne Girling, Anne Y. Warren, Ian G. Mills, Kanagasabai Sahadevan, Hing Leung, Freddie Hamdy, Hayley C. Whitaker, David E. Neal
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (9): 3003–3013.
https://doi.org/10.1158/1078-0432.CCR-08-2046
Published: 30 April 2009
View article titled, LYRIC/AEG-1 Is Targeted to Different Subcellular Compartments by Ubiquitinylation and Intrinsic Nuclear Localization Signals
Open the PDF for LYRIC/AEG-1 Is Targeted to Different Subcellular Compartments by Ubiquitinylation and Intrinsic Nuclear Localization Signals in another window
Includes: Supplementary data
Journal Articles

High-Resolution Array-Based Comparative Genomic Hybridization of Bladder Cancers Identifies Mouse Double Minute 4 (MDM4) as an Amplification Target Exclusive of MDM2 and TP53

Free
Abhi Veerakumarasivam, Helen E. Scott, Suet-Feung Chin, Anne Warren, Matthew J. Wallard, Donna Grimmer, Koichi Ichimura, Carlos Caldas, V. Peter Collins, David E. Neal, John D. Kelly
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (9): 2527–2534.
https://doi.org/10.1158/1078-0432.CCR-07-4129
Published: 01 May 2008
View article titled, High-Resolution Array-Based Comparative Genomic Hybridization of Bladder Cancers Identifies Mouse Double Minute 4 (MDM4) as an Amplification Target Exclusive of MDM2 and TP53
Open the PDF for High-Resolution Array-Based Comparative Genomic Hybridization of Bladder Cancers Identifies Mouse Double Minute 4 (MDM4) as an Amplification Target Exclusive of MDM2 and TP53 in another window
Includes: Supplementary data
Journal Articles

Evaluation of the Therapeutic Potential of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib in Preclinical Models of Bladder Cancer

Free
Jose L. Dominguez-Escrig, John D. Kelly, David E. Neal, Sonya M. King, Barry R. Davies
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (14): 4874–4884.
https://doi.org/10.1158/1078-0432.CCR-04-0034
Published: 21 July 2004
View article titled, Evaluation of the Therapeutic Potential of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib in Preclinical Models of Bladder Cancer
Open the PDF for Evaluation of the Therapeutic Potential of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib in Preclinical Models of Bladder Cancer in another window
Journal Articles

Alteration in Urinary Matrix Metalloproteinase-9 to Tissue Inhibitor of Metalloproteinase-1 Ratio Predicts Recurrence in Nonmuscle-invasive Bladder Cancer

Free
Garrett C. Durkan, Joyce E. Nutt, Colin Marsh, Paul H. Rajjayabun, Mary C. Robinson, David E. Neal, John Lunec, J. Kilian Mellon
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (7): 2576–2582.
Published: 01 July 2003
View article titled, Alteration in Urinary Matrix Metalloproteinase-9 to Tissue Inhibitor of Metalloproteinase-1 Ratio Predicts Recurrence in Nonmuscle-invasive Bladder Cancer
Open the PDF for Alteration in Urinary Matrix Metalloproteinase-9 to Tissue Inhibitor of Metalloproteinase-1 Ratio Predicts Recurrence in Nonmuscle-invasive Bladder Cancer in another window
Journal Articles

Prognostic Significance of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-1 in Voided Urine Samples from Patients with Transitional Cell Carcinoma of the Bladder

Free
Garrett C. Durkan, Joyce E. Nutt, Paul H. Rajjayabun, David E. Neal, John Lunec, J. Kilian Mellon
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (11): 3450–3456.
Published: 01 November 2001
View article titled, Prognostic Significance of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-1 in Voided Urine Samples from Patients with Transitional Cell Carcinoma of the Bladder
Open the PDF for Prognostic Significance of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-1 in Voided Urine Samples from Patients with Transitional Cell Carcinoma of the Bladder in another window
Journal Articles

Peroxisome Proliferator-activated Receptor α Is an Androgen-responsive Gene in Human Prostate and Is Highly Expressed in Prostatic Adenocarcinoma

Free
Gavin P. Collett, Alan M. Betts, Mark I. Johnson, Anna B. Pulimood, Susan Cook, David E. Neal, Craig N. Robson
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (8): 3241–3248.
Published: 01 August 2000
View article titled, Peroxisome Proliferator-activated Receptor α Is an Androgen-responsive Gene in Human Prostate and Is Highly Expressed in Prostatic Adenocarcinoma
Open the PDF for Peroxisome Proliferator-activated Receptor α Is an Androgen-responsive Gene in Human Prostate and Is Highly Expressed in Prostatic Adenocarcinoma in another window